PrecisionMed
PrecisionMed supplies human biological samples—primarily cerebrospinal fluid, serum, plasma, FFPE tissue, and matched biofluids—to pharmaceutical, biotechnology, academic, and government researchers for drug discovery, biomarker research, and molecular diagnostics. Now a BioIVT subsidiary.
- Company typePrivate
- Founded1996
- HeadquartersSolana Beach, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What PrecisionMed does
PrecisionMed is a US-based human biospecimen supplier operating as a subsidiary of BioIVT since its 2024 acquisition. The company provides pharmaceutical, biotechnology, and academic and government research institutions with high-quality, IRB-approved human biological samples—including cerebrospinal fluid (CSF), serum, plasma, FFPE tissue, DNA/RNA, and urine—collected longitudinally with detailed HIPAA-compliant clinical metadata. Its core differentiation is the position as the world's largest private global source of longitudinally collected human CSF, anchored by the proprietary TruNormal® control samples that serve as matched controls for diseased material in neuroscience research.
The underlying technology combines a predictive biobanking inventory model with standardized collection and quality control procedures executed through validated clinical sites under US IRB-approved protocols. Samples are annotated with cognitive rating scales, demographics, family history, medical history, and longitudinal treatment data collected prospectively over multiple visits. The portfolio spans three primary verticals—neurology (the flagship CSF and matched biospecimen business), oncology (45,000+ archived FFPE blocks plus paired liquid biopsy collections), and emerging cell and gene therapy support—with a Custom Collections service enabling bespoke procurement for non-standard requests. The current inventory comprises 125,000+ banked samples, 1,500+ individual neurology donors, and 170,000+ guaranteed samples ready to ship.
PrecisionMed monetizes through direct one-time sample sales under a quote-based pricing model with no public rate cards, operating exclusively via direct B2B enterprise sales through its website and sales engagement. Samples ship within days of order and customers retain 100% of sample rights post-purchase with no royalties. The customer base of 600+ institutions globally includes nearly every major pharmaceutical and biotechnology company and named accounts such as Harvard Medical School, Biogen, and GlaxoSmithKline. Marketing and customer acquisition rely on 120+ scientific journal citations referencing PrecisionMed samples, the website Request Inventory form, and a clinical site Partner With Us program, rather than traditional demand-generation channels.
PrecisionMed firmographics
Firmographics- Name
- PrecisionMed
- Legal name
- PrecisionMed, Inc.
- Website
- https://precisionmed.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- PrecisionMed supplies human biological samples—primarily cerebrospinal fluid, serum, plasma, FFPE tissue, and matched biofluids—to pharmaceutical, biotechnology, academic, and government researchers for drug discovery, biomarker research, and molecular diagnostics. Now a BioIVT subsidiary.
- Ownership category
- akta.pro rank
PrecisionMed industry classification
Industry- Product category
- Biorepository and Biospecimen Supply Services
- NAICS
- Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Biomarker Discovery & Validation (omics, assay feasibility, clinical validation) (HLAAAMAA)
- akta.pro secondary industries
- Clinical Trial Sample Collection & Site Phlebotomy Services (HLAGACAJ), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Proteomics & Biomarker Analytical Testing (HLAGADAG)
Keywords
Where PrecisionMed is headquartered
LocationHeadquarters
- HQ city
- Solana Beach
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
PrecisionMed business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Human Biological Sample Sales: Direct sale of human biological specimens including CSF, serum, plasma, tissue, DNA/RNA, and urine samples to pharmaceutical, biotechnology, and academic researchers. Samples are sold with detailed clinical data and ship immediately upon order.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
PrecisionMed product offering
Product offeringCore offering
PrecisionMed supplies high-quality human biological samples—primarily cerebrospinal fluid (CSF), serum, plasma, FFPE tissue, DNA/RNA, urine, and CSF cell pellets—collected longitudinally under US IRB-approved protocols and annotated with detailed HIPAA-compliant clinical data. Its proprietary TruNormal® controls are the world's only commercially available vetted normal control biospecimens. Samples are sold directly to pharmaceutical, biotechnology, academic, and government researchers for drug discovery, biomarker research, molecular diagnostics development, and genetics studies.
Product overview
PrecisionMed is a human biological sample biorepository and supplier, operating as a subsidiary of BioIVT. Its portfolio centers on high-quality, IRB-approved human biospecimens — primarily cerebrospinal fluid (CSF), serum, plasma, FFPE tissue, DNA/RNA, and urine — collected longitudinally with detailed clinical data. The core product is its neurology CSF biorepository, the world's largest private global source of diseased and TruNormal control CSF. TruNormal Controls (the world's only supplier of proprietary normal biological samples) serve as matched controls across the portfolio. Sample types span from primary CSF collections and matched biofluids (PAXGene RNA, serum, plasma, blood cell pellet, urine) to FFPE tissue blocks (45,000+ archived) and liquid biopsy paired samples. Oncology samples provide FFPE tissue and matched biofluids for solid tumor research. The portfolio also includes custom collection services and cell/gene therapy support. All samples include detailed donor clinical data (diagnosis, demographics, family history, rating scales) and are available immediately.
Differentiator
Problem solved
Functional benefit
Brands
- TruNormal®: Proprietary normal control biological samples from donors with normal cognition, no history of significant neurological or neuropsychiatric disease
Quantifiable outcome
- Samples ship within 3 days of order
- +2 more outcomes
Companies that use PrecisionMed
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
PrecisionMed technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
PrecisionMed partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- BioIVTflagshipPrecisionMed has been acquired by BioIVT, becoming 'PrecisionMed, a BioIVT Company.' This acquisition integrates PrecisionMed's extensive CSF and neurology sample biorepository into BioIVT's broader portfolio of human biological samples for research. The acquisition enhances BioIVT's position as a leading supplier of high-quality human biological material while maintaining PrecisionMed's brand identity and operations.
Scale indicators10 records
Recent moves6 records
Expansion highlights5 records
PrecisionMed competitors and assessment
Company assessmentDirect peers
- Boca Biolistics: Supplier of human biospecimens including tissue, biofluids, and cells for research and diagnostics development. Comparable as a multi-specialty biospecimen provider serving pharma, biotech, and academic researchers with annotated samples.
- iSpecimen: Online marketplace for human biospecimens connecting researchers with healthcare providers supplying tissue, biofluids, and cells. Comparable in business model of supplying diverse human samples to research customers, though iSpecimen uses a marketplace approach versus PrecisionMed's owned biorepository.
- Cureline: Human biospecimen CRO providing tissue, blood, and biofluid samples with clinical data from global clinical sites. Comparable in business model of prospectively collecting and supplying characterized human samples for research and drug discovery.
- Tissue Solutions (a Bio-Techne brand): Supplies human tissue samples and biofluids to researchers globally. Directly comparable in supplying characterized human biospecimens with clinical data to pharma and academic researchers across multiple therapeutic areas.
- Indivumed: Specialized in oncology biospecimens with detailed clinical annotation from cancer patients. Comparable as a specialty biospecimen provider focused on a single therapeutic area (oncology), similar to PrecisionMed's neurology focus.
- Discovery Life Sciences: Global provider of biospecimens and bioanalytic services to pharma/biotech. Directly comparable in supplying characterized human samples with clinical data for biomarker and drug discovery research, with overlapping offerings in tissue, biofluids, and cell products.
Broad incumbents
- Bio-Techne: Large life sciences tools company with a biospecimen division (Tissue Solutions) plus broader proteomics and cell biology product lines. Comparable as a parent-level player in biospecimen supply with additional research tools portfolio.
- Charles River Laboratories: Major CRO offering research models, biospecimens, and preclinical services. Comparable as a large incumbent serving pharma/biotech research needs with biological materials and laboratory services, though biospecimens are a smaller segment within its broader portfolio.
- BioIVT: Parent company of PrecisionMed and the largest commercial supplier of human biospecimens globally. Directly comparable as both supply human biological samples to pharma/biotech researchers with overlapping product lines including tissues, biofluids, and cells.
Emerging players
- ZenBio: Specialized provider of human primary cells, tissues, and biofluids for research. Comparable in supplying characterized human biological materials to research customers, with overlap in tissue and biofluid product categories.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
PrecisionMed social profiles
Digital presencePrecisionMed financial estimates
Financial estimateRevenue estimate
Valuation estimate
PrecisionMed leadership team
Management profileNumber of profiles
Profiles3 records
PrecisionMed funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PrecisionMed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PrecisionMed
What does PrecisionMed do?
PrecisionMed supplies high-quality human biological samples—primarily cerebrospinal fluid (CSF), serum, plasma, FFPE tissue, DNA/RNA, urine, and CSF cell pellets—collected longitudinally under US IRB-approved protocols and annotated with detailed HIPAA-compliant clinical data. Its proprietary TruNormal® controls are the world's only commercially available vetted normal control biospecimens. Samples are sold directly to pharmaceutical, biotechnology, academic, and government researchers for drug discovery, biomarker research, molecular diagnostics development, and genetics studies.
Is PrecisionMed a public or private company?
PrecisionMed is a private company. It is classified as corporate owned and is currently operating.
When was PrecisionMed founded?
PrecisionMed was founded in 1996. It employs 101 to 250 people.
Where is PrecisionMed based?
PrecisionMed is headquartered in Solana Beach, United States, in the North America region.
How does PrecisionMed make money?
One revenue line is on record: human Biological Sample Sales.
Who are PrecisionMed's main competitors?
Direct peers on record are Boca Biolistics, iSpecimen, Cureline, Tissue Solutions (a Bio-Techne brand), Indivumed and Discovery Life Sciences. Broad incumbents are Bio-Techne, Charles River Laboratories and BioIVT. ZenBio is listed as an emerging player.
Does PrecisionMed have an API?
No public API is recorded for PrecisionMed.
What industry is PrecisionMed in?
PrecisionMed's product category is Biorepository and Biospecimen Supply Services. Its primary akta.pro industry code is HLAAAMAA, Biomarker Discovery & Validation (omics, assay feasibility, clinical validation), with a secondary code of HLAGACAJ, Clinical Trial Sample Collection & Site Phlebotomy Services. Its NAICS code is 621511 and its SIC code is 8071.